Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cyclahexadiene derivatives reported by Bayer for AD

March 15, 1996

Myloral development update

March 15, 1996

Yamanouchi claims PCP antagonist for dementia

March 15, 1996

BB-3644 in development for multiple sclerosis

March 15, 1996

Lexipafant evaluated for MS treatment

March 15, 1996

Yissum claims novel anticonvulsants

March 15, 1996

Cephalon reports modafinil study results

March 15, 1996

Zeneca acquires antimigraine drug

March 15, 1996

Abbott and Purdue Pharma to copromote analgesic

March 15, 1996

Hoechst Marion Roussel claims new analgesics

March 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...